Showing 481-500 of 503 for: Cochrane Systematic Reviews > Neurologic 
- Treatment of seizures in multiple sclerosis
Cochrane Systematic Reviews, 29-Apr-2009
Epileptic seizures occur in only a minority of patients with multiple sclerosis (MS), but can have serious consequences. The available literature suggests an association of seizures in MS with cortical and subcortical demyelinating lesions, which suggest
- Tricyclic antidepressants for autism spectrum disorders (ASD) in children and adolescents
Cochrane Systematic Reviews, 16-Feb-2012
Autism spectrum disorders (ASD) are a heterogeneous group of neurodevelopmental disorders, ranging in severity and characterised by early onset of delay and deviance in the development of social interaction, and verbal and nonverbal communication. ASD is
- Triptans for acute cluster headache
Cochrane Systematic Reviews, 16-Jul-2013
This is an updated version of the original Cochrane review published in Issue 4, 2010 (Law 2010). Cluster headache is an uncommon, severely painful, and disabling condition, with rapid onset. Validated treatment options are limited; first-line therapy inc
- Ultrasound guidance for upper and lower limb blocks
Cochrane Systematic Reviews, 20-Aug-2015
Peripheral nerve blocks can be performed using ultrasound guidance. It is not yet clear whether this method of nerve location has benefits over other existing methods. This review was originally published in 2009 and was updated in 2014.
- Vaccines for preventing Japanese encephalitis
Cochrane Systematic Reviews, 9-Nov-2008
Vaccination is recognized as the only practical measure for preventing Japanese encephalitis. Production shortage, costs, and issues of licensure impair vaccination programmes in many affected countries. Concerns over vaccine effectiveness and safety also
- Vaccines for preventing tick-borne encephalitis
Cochrane Systematic Reviews, 11-Nov-2008
Tick-borne encephalitis (TBE) is a disease of the central nervous system caused by a tick-borne viral infection. TBE can lead to severe neurological syndromes such as meningitis, meningoencephalitis, and meningoencephalomyelitis, which can result in death
- Vagus nerve stimulation for focal seizures
Cochrane Systematic Reviews, 14-Jul-2022
This is an updated version of the Cochrane Review published in 2015.
- Validation therapy for dementia
Cochrane Systematic Reviews, 6-Nov-2008
Validation therapy was developed by Naomi Feil between 1963 and 1980 for older people with cognitive impairments. Initially, this did not include those with organically-based dementia, but the approach has subsequently been applied in work with people who
- Valproate preparations for agitation in dementia
Cochrane Systematic Reviews, 9-Nov-2010
Agitation affects up to 70% of older people with dementia. Valproic acid derivatives have been used for the past 10 years to control agitation in dementia, but no systematic review of the effectiveness of this treatment has been published to date. A syste
- Velnacrine for Alzheimer's disease
Cochrane Systematic Reviews, 12-May-2008
Alzheimer's disease (AD) is the commonest cause of dementia affecting older people. One of the therapeutic strategies aimed at ameliorating the clinical manifestations of Alzheimer's disease is to enhance cholinergic neurotransmission in relevant parts of
- Vestibular rehabilitation for unilateral peripheral vestibular dysfunction
Cochrane Systematic Reviews, 11-Jan-2015
This is an update of a Cochrane review first published in The Cochrane Library in Issue 4, 2007 and previously updated in 2011.
- Vigabatrin versus carbamazepine monotherapy for epilepsy
Cochrane Systematic Reviews, 17-Nov-2015
This is an update of a Cochrane review first published in 2012 (Cochrane Database of Systematic Reviews 2012, Issue 1).
- Vinpocetine for cognitive impairment and dementia
Cochrane Systematic Reviews, 29-Apr-2009
Vinpocetine is a synthetic ethyl ester of apovincamine, a vinca alkaloid obtained from the leaves of the Lesser Periwinkle (Vinca minor) and discovered in the late 1960s. Although used in human treatment for over twenty years, it has not been approved by
- Vitamin B12 for cognition
Cochrane Systematic Reviews, 6-Nov-2008
An association between neuropsychiatric disorders and vitamin B12 deficiency has been recognized since 1849 when pernicious anaemia was first described. It has been suggested that deficiency of vitamin B12 might contribute to age-associated cognitive impa
- Vitamin B6 for cognition
Cochrane Systematic Reviews, 12-May-2008
Micronutrient status can affect cognitive function at all ages. Vitamin deficiencies could influence memory function and might contribute to age-associated cognitive impairment and dementia. Vitamin B6, comprising three chemically distinct compounds, pyri
- Vitamin D for the management of multiple sclerosis
Cochrane Systematic Reviews, 2-Nov-2010
Multiple sclerosis is a disease of the central nervous system characterized by demyelination of the nerve sheaths which can result in varying levels of disability. Disease occurrence and progression are considered by some to be associated with low serum l
- Vitamin E for Alzheimer's dementia and mild cognitive impairment
Cochrane Systematic Reviews, 12-Oct-2012
Vitamin E is a dietary compound that functions as an antioxidant scavenging toxic free radicals. Evidence that free radicals may contribute to the pathological processes of cognitive impairment including Alzheimer's disease has led to interest in the use
- Vitamin E for neuroleptic-induced tardive dyskinesia
Cochrane Systematic Reviews, 4-Oct-2011
Antipsychotic (neuroleptic) medication is used extensively to treat people with chronic mental illnesses. Its use, however, is associated with adverse effects, including movement disorders such as tardive dyskinesia (TD) – a problem often seen as repetiti
- Vitamins for epilepsy
Cochrane Systematic Reviews, 10-Aug-2009
Vitamins have been reported to be effective in controlling certain types of seizures and to prevent some of the harmful effects of antiepileptic drugs (AEDs). In this review we will summarize evidence from randomized controlled trials.
- Yizhi capsule for vascular dementia
Cochrane Systematic Reviews, 12-Jan-2009
Vascular dementia (VD) is a syndrome or diagnosis that has different causes and clinical manifestations relating to several different vascular mechanisms and changes in the brain. Some traditional Chinese herbal medicines were developed for treating VD. Y
